多囊卵巢综合征女性心血管代谢健康的生活方式干预:系统综述与网状Meta分析
该研究纳入43项随机对照试验共2433名多囊卵巢综合征女性,采用贝叶斯网状Meta分析比较多种生活方式干预对16项心血管代谢结局的效果。生酮饮食可能降低腰围和体重指数,有氧运动、身心运动及高强度间歇训练在多个代谢指标上排名靠前,证据确定性普遍为低或极低。
要点
- 生酮饮食可降低腰围(MD -5.74 cm)和体重指数(MD -2.61 kg/m²)。
- 身心运动在改善胰岛素抵抗、空腹血糖、甘油三酯、空腹胰岛素和低密度脂蛋白胆固醇方面排名最佳。
- 每周约480-1012 METs·min的运动剂量与多个结局预测获益重叠最大。
核心结论
- 生酮饮食可能降低多囊卵巢综合征女性的腰围和体重指数。
- 高强度间歇训练和身心运动在多个心血管代谢结局上显示有益。
- 每周约480-1012 METs·min的运动剂量与多个结局预测获益重叠最大。
- 证据确定性普遍为低或极低,部分估计基于有限研究数,需谨慎解读。
研究设计与样本
- 系统检索五个数据库从建库至2026年6月9日的随机对照试验。
- 纳入针对多囊卵巢综合征女性心血管代谢结局的生活方式干预研究。
- 排除药物干预或干预时长小于2周的研究。
- 最终纳入43项研究共2433名参与者。
- 采用基于臂的多水平贝叶斯随机效应网状Meta分析,效应量为均数差(MD)及95%可信区间(CrIs)。
主要发现
- 与相应对照条件相比,生酮饮食降低腰围(No=86,k=2;MD=-5.74 cm,95% CrIs -8.48至-3.04)和体重指数(No=86,k=2;MD=-2.61 kg/m²,-4.53至-0.77)。
- 有氧运动在降低腰臀比方面排名最佳(No=141,k=7;MD=-0.03,-0.04至-0.02),在降低收缩压方面也排名最佳(No=90,k=4;MD=-3.49 mmHg,95% CrI -6.87至-0.09)。
- 身心运动在降低HOMA-IR(No=72,k=3;MD=-0.63,-1.06至-0.24)、空腹血糖(No=37,k=2;MD=-0.16 mmol/l,-0.31至-0.03)、甘油三酯(No=59,k=2;MD=-0.28 mmol/l,-0.55至-0.01)、空腹胰岛素(No=72,k=3;MD=-6.26 pmol/l,-12.14至-0.50)和低密度脂蛋白胆固醇(No=59,k=2;MD=-0.26 mmol/l,-0.42至-0.14)方面排名最佳。
- 高强度间歇训练在改善高密度脂蛋白胆固醇方面排名最佳(No=117,k=6;MD=0.05 mmol/l,0.01至0.10)。
- 每周约480-1012 METs·min的运动剂量与多个心血管代谢结局预测获益重叠最大;中等至剧烈强度7.2-9.4 METs、每次60分钟、每周3次、持续13-17周主要与脂质结局的预测有利变化相关。
关键数值与推荐
- 生酮饮食降低腰围MD=-5.74 cm(95% CrIs -8.48至-3.04),降低体重指数MD=-2.61 kg/m²(-4.53至-0.77)。
- 有氧运动降低腰臀比MD=-0.03(-0.04至-0.02),降低收缩压MD=-3.49 mmHg(95% CrI -6.87至-0.09)。
- 身心运动降低HOMA-IR MD=-0.63(-1.06至-0.24),降低空腹血糖MD=-0.16 mmol/l(-0.31至-0.03)。
- 身心运动降低甘油三酯MD=-0.28 mmol/l(-0.55至-0.01),降低空腹胰岛素MD=-6.26 pmol/l(-12.14至-0.50),降低低密度脂蛋白胆固醇MD=-0.26 mmol/l(-0.42至-0.14)。
- 高强度间歇训练升高高密度脂蛋白胆固醇MD=0.05 mmol/l(0.01至0.10)。
临床怎么用
- 生酮饮食可考虑用于改善多囊卵巢综合征女性的腰围和体重指数。
- 身心运动可作为改善胰岛素抵抗、血糖和血脂谱的优先选择之一。
- 有氧运动可用于降低腰臀比和收缩压,高强度间歇训练可用于改善高密度脂蛋白胆固醇。
- 运动处方可参考每周约480-1012 METs·min的剂量,但需结合证据确定性低的情况个体化决策。
局限性
- 总体证据确定性普遍评为低或极低。
- 部分估计基于有限数量的研究。
- 研究结果应谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Women with polycystic ovary syndrome (PCOS) face an elevated long-term risk of type 2 diabetes and cardiovascular disease, largely driven by clustered cardiometabolic abnormalities. Although lifestyle interventions primarily involving exercise and dietary interventions have shown benefits, the optimal strategy remains uncertain. OBJECTIVE AND RATIONALE: We aimed to systematically evaluate and compare multiple lifestyle interventions for cardiometabolic outcomes in women with PCOS, and explore potential dose-response relationships between intervention effects and key covariates such as exercise dose. Outcomes were grouped into five domains: anthropometry and body composition, glucose and insulin regulation, blood lipid profiles, inflammation, and blood pressure, together comprising 16 outcomes. This study was designed to address the limited comparative evidence across lifestyle interventions and the lack of quantitative evidence on factors that may modify intervention effects, with the aim of informing individualized lifestyle prescriptions and cardiometabolic risk management in women with PCOS. SEARCH METHODS: A systematic search across five databases retrieved randomized controlled trials of lifestyle interventions in PCOS, spanning records from inception to 9 June 2026, including lifestyle interventions targeting cardiometabolic outcomes in women with PCOS. Studies involving pharmacological interventions or with an intervention duration of <2 weeks were excluded. An arm-based multilevel Bayesian random-effects network meta-analysis was used to synthesize arm-level change scores as mean differences (MD), with effects reported as MDs and 95% credible intervals (CrIs); treatments were ranked using the surface under the cumulative ranking curve (SUCRA). The risk of bias was assessed using the Cochrane Risk of Bias tool 2, and the confidence in each network estimate was evaluated using the Confidence in Network Meta-Analysis (CINeMA) framework. OUTCOMES: After exclusions, 43 studies with 2433 participants were included. Compared with the respective control condition, within the dietary network, the ketogenic diet reduced waist circumference (No (number of participants) = 86, k (number of study arms) = 2; MD = -5.74 cm, 95% CrIs -8.48 to -3.04) and body mass index (No = 86, k = 2; MD = -2.61 kg/m², -4.53 to -0.77). Meanwhile, within the exercise network, aerobic exercise ranked best for reducing waist to hip ratio (No = 141, k = 7; MD = -0.03, -0.04 to - 0.02), mind-body exercise ranked best for reducing insulin resistance assessed by the homeostatic model assessment of insulin resistance (HOMA-IR) (No = 72, k = 3; MD = -0.63, -1.06 to -0.24), fasting plasma glucose (No = 37, k = 2; MD = - 0.16 mmol/l, -0.31 to -0.03), triglycerides (No = 59, k = 2; MD = -0.28 mmol/l, -0.55 to -0.01), fasting insulin (No = 72, k = 3; MD = -6.26 pmol/l, -12.14 to -0.50) and low-density lipoprotein cholesterol (No = 59, k = 2; MD = -0.26 mmol/l, -0.42 to -0.14), and high-intensity interval training (HIIT) ranked best for improving high-density lipoprotein cholesterol (No = 117, k = 6; MD = 0.05 mmol/l, 0.01 to 0.10). Aerobic exercise also ranked best for reducing systolic blood pressure (No = 90, k = 4; MD = -3.49 mmHg; 95% CrI, -6.87 to -0.09). Overall, the certainty of evidence was generally rated as low or very low. An exercise dose of approximately 480-1012 metabolic equivalents of task (METs)·min/week was associated with the greatest overlap in predicted benefits across multiple cardiometabolic outcomes, and moderate-to-vigorous intensity exercise of 7.2-9.4 METs, 60 min/session, 3 sessions/week for 13-17 weeks was mainly associated with predicted favourable changes in lipid outcomes. WIDER IMPLICATIONS: Collective evidence suggests that the ketogenic diet may reduce waist circumference and body mass index; HIIT and mind-body exercise appeared beneficial across multiple cardiometabolic outcomes. An exercise dose of approximately 480-1012 METs·min/week was associated with the greatest overlap in predicted benefits across outcomes. However, these findings should be interpreted cautiously because the certainty of evidence was generally low or very low, and some estimates were based on a limited number of studies. Nevertheless, this study provides a more targeted basis for exercise prescription and future research in PCOS. REGISTRATION NUMBER: CRD420251079107.
引用
- Zhang X, Liang Z, Sabag A, et al. Lifestyle interventions for cardiometabolic health in women with polycystic ovary syndrome: a systematic review and network meta-analysis. Hum Reprod Update. 2026. PMID: 42854088. doi:10.1093/humupd/dmag032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。